Désirée van der Heijde Selected Research

drotaverin (No-spa)

1/2020	What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts.
12/2018	Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis.
1/2016	Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?
11/2015	Classification of axial SpA based on positive imaging (radiographs and/or MRI of the sacroiliac joints) by local rheumatologists or radiologists versus central trained readers in the DESIR cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Désirée van der Heijde Research Topics

Disease

123	Rheumatoid Arthritis 03/2022 - 01/2002
93	Ankylosing Spondylitis 11/2022 - 03/2003
59	Axial Spondyloarthritis 10/2022 - 02/2011
43	Inflammation (Inflammations) 01/2022 - 05/2006
41	Psoriatic Arthritis 10/2022 - 07/2003
28	Necrosis 11/2022 - 05/2010
26	Pain (Aches) 01/2022 - 02/2005
24	Arthritis (Polyarthritis) 01/2022 - 07/2003
21	Infections 01/2022 - 07/2006
20	Rheumatic Diseases (Rheumatism) 01/2021 - 01/2007
17	Back Pain (Backache) 01/2020 - 11/2011
16	Non-Radiographic Axial Spondyloarthritis 01/2022 - 06/2013
13	Sacroiliitis 01/2022 - 11/2011
12	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 05/2007
7	Synovitis 01/2020 - 05/2010
7	Osteoarthritis 01/2019 - 11/2006
6	Injection Site Reaction 01/2020 - 06/2009
5	Neoplasms (Cancer) 11/2022 - 01/2017
5	Herpes Zoster 01/2022 - 10/2017
4	Uveitis 06/2022 - 08/2015
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 06/2009
4	Nasopharyngitis 01/2022 - 09/2015
4	Gout 12/2021 - 01/2003
4	Fatigue 09/2020 - 08/2003
4	Spondylarthropathies 01/2019 - 08/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 08/2015
2	Venous Thromboembolism 11/2022 - 01/2020
2	Edema (Dropsy) 01/2022 - 07/2017
2	Headache (Headaches) 01/2022 - 06/2009
2	Nausea 12/2021 - 09/2014

Drug/Important Bio-Agent (IBA)

59	Antirheumatic Agents (DMARD)IBA 11/2022 - 01/2003
51	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2003
43	C-Reactive ProteinIBA 03/2022 - 02/2005
36	Biological ProductsIBA 11/2022 - 01/2009
30	Adalimumab (Humira)FDA Link 01/2021 - 07/2006
23	Certolizumab Pegol FDA Link 01/2022 - 07/2012
22	golimumab FDA Link 01/2022 - 09/2010
22	Etanercept (Enbrel)FDA Link 01/2021 - 02/2004
18	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2021 - 02/2011
16	Tumor Necrosis Factor InhibitorsIBA 10/2022 - 07/2003
16	tofacitinibIBA 01/2021 - 03/2013
16	Infliximab (Remicade)FDA Link 01/2020 - 02/2005
16	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2007
15	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2019 - 03/2003
13	Monoclonal AntibodiesIBA 01/2022 - 07/2006
13	GlucocorticoidsIBA 12/2021 - 03/2014
12	Interleukin-17 (Interleukin 17)IBA 11/2022 - 11/2013
12	Janus Kinase InhibitorsIBA 11/2022 - 06/2016
11	secukinumabIBA 01/2020 - 11/2013
10	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 01/2003
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2006
9	ixekizumabIBA 01/2022 - 01/2017
9	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2020 - 11/2011
8	baricitinibIBA 01/2022 - 01/2014
8	tocilizumab (atlizumab)FDA Link 01/2020 - 09/2007
8	Abatacept (Orencia)FDA Link 01/2020 - 01/2013
8	Pharmaceutical PreparationsIBA 12/2018 - 01/2003
6	Denosumab FDA Link 11/2021 - 05/2008
6	Proteins (Proteins, Gene)FDA Link 04/2021 - 08/2007
6	sarilumabIBA 01/2020 - 06/2015
6	Interleukin-6 (Interleukin 6)IBA 12/2016 - 09/2007
5	Janus KinasesIBA 01/2020 - 01/2017
5	Biosimilar PharmaceuticalsIBA 01/2020 - 01/2014
5	Rheumatoid FactorIBA 03/2017 - 05/2007
5	Naproxen (Naprosyn)FDA LinkGeneric 07/2015 - 01/2003
4	upadacitinibIBA 11/2022 - 12/2019
4	guselkumabIBA 01/2022 - 01/2020
4	Uric Acid (Urate)IBA 12/2021 - 01/2003
4	GLPG0634IBA 01/2021 - 12/2018
4	Prostaglandins AIBA 01/2021 - 08/2010
4	drotaverin (No-spa)IBA 01/2020 - 11/2015
4	InterleukinsIBA 01/2020 - 02/2014
4	ametantrone (HAQ)IBA 01/2018 - 01/2015
4	Prednisolone (Predate)FDA LinkGeneric 07/2014 - 01/2003
3	Immunoglobulin A (IgA)IBA 01/2022 - 03/2017
3	AntibodiesIBA 04/2021 - 01/2011
3	apremilastIBA 01/2021 - 01/2014
3	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 01/2014
3	CytokinesIBA 01/2020 - 11/2013
3	Rituximab (Mabthera)FDA Link 01/2020 - 03/2014
3	4-hexyloxyaniline (HOA)IBA 01/2019 - 06/2011
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2018 - 08/2007
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 01/2016
3	Analgesics (Analgesic Drugs)IBA 06/2017 - 10/2011
3	AntigensIBA 01/2017 - 11/2011
3	GadoliniumIBA 05/2015 - 07/2013
3	Anti-Citrullinated Protein AntibodiesIBA 07/2014 - 01/2010
3	Diclofenac (SR 38)FDA LinkGeneric 11/2006 - 01/2003
2	bimekizumabIBA 07/2022 - 01/2020
2	peficitinibIBA 03/2022 - 10/2019
2	Interleukin-23 (Interleukin 23)IBA 01/2022 - 01/2020

Therapy/Procedure

60	Therapeutics 01/2022 - 01/2002
6	Aftercare (After-Treatment) 01/2020 - 05/2006
5	Drug Therapy (Chemotherapy) 01/2022 - 03/2012
4	Drug Tapering 10/2022 - 01/2020
4	Pain Management 09/2012 - 10/2011
3	Contraindications 01/2021 - 06/2013
3	Injections 01/2020 - 12/2016
3	Subcutaneous Injections 11/2013 - 05/2012
2	Biological Therapy 11/2022 - 01/2017